Previous Close | 14.60 |
Open | 15.10 |
Bid | 14.70 x N/A |
Ask | 15.10 x N/A |
Day's Range | 15.10 - 15.10 |
52 Week Range | 8.60 - 18.70 |
Volume | |
Avg. Volume | 17 |
Market Cap | 404.999M |
Beta (5Y Monthly) | 1.38 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.29 |
Earnings Date | May 09, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 40.60 |
Subscribe to Yahoo Finance Plus to view Fair Value for 51KA.F
Viewing insider transactions for AVITA Medical, Inc.'s ( NASDAQ:RCEL ) over the last year, we see that insiders were...
VALENCIA, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced it has submitted its response to the U.S. Food and Drug Administration (FDA) for additional information requested in connection to its premarket approval (PMA) supplement for RECELL GO™. This submission resumes the substantive interactive review process u
VALENCIA, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that David O’Toole, Chief Financial Officer, will present at TD Cowen’s 44th Annual Health Care Conference on Tuesday, March 5, 2024, at 9:50 a.m. Eastern Time. A live audio webcast of the presentation will be available under the Events & Presentations se